BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 310050)

  • 1. Diabetic retinopathy and colour discrimination under various illuminants.
    Barca L; Vaccari G
    Mod Probl Ophthalmol; 1978; 19():301-4. PubMed ID: 310050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An averaging method for the interpretation of the Farnsworth-Munsell 100-Hue Test--II. Colour vision defects acquired in diabetic retinopathy.
    Birch J; Dain SJ
    Ophthalmic Physiol Opt; 1987; 7(3):281-91. PubMed ID: 3500447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colour discrimination under C and high-pressure Na illumination in normals and patients affected by various diseases.
    Serra A; Mascia C; Dessy C
    Mod Probl Ophthalmol; 1978; 19():281-3. PubMed ID: 723863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenon arc and argon laser photocoagulation in the treatment of diabetic disc neovascularization. Part 2. Effect on colour vision.
    Birch J; Hamilton AM
    Trans Ophthalmol Soc U K (1962); 1981; 101(1):93-9. PubMed ID: 6192563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farnsworth-Munsell 100-hue test for patients with diabetes mellitus.
    Utku D; Atmaca LS
    Ann Ophthalmol; 1992 Jun; 24(6):205-8. PubMed ID: 1444079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetes and color vision disorder detected by the Farnsworth 100 Hue test. Diabetic dyschromatopsia].
    Ayed S; Jeddi A; Kallal Z
    J Fr Ophtalmol; 1990; 13(10):506-10. PubMed ID: 2081841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hue discrimination and S cone pathway sensitivity in early diabetic retinopathy.
    Greenstein V; Sarter B; Hood D; Noble K; Carr R
    Invest Ophthalmol Vis Sci; 1990 Jun; 31(6):1008-14. PubMed ID: 2354907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diabetic eye and colour vision.
    Kinnear PR; Aspinall PA; Lakowski R
    Trans Ophthalmol Soc U K (1962); 1972; 92():69-78. PubMed ID: 4541523
    [No Abstract]   [Full Text] [Related]  

  • 9. Chromatic-contrast threshold impairment in diabetes.
    Tregear SJ; Knowles PJ; Ripley LG; Casswell AG
    Eye (Lond); 1997; 11 ( Pt 4)():537-46. PubMed ID: 9425421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of color vision disturbances in diagnostics of early diabetic retinopathy].
    Mulak M; Reniewska B; Kostuś E; Balcewicz A; Misiuk-Hojło M
    Klin Oczna; 2002; 104(3-4):249-51. PubMed ID: 12608311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The AN-59 anomaloscope in the research of acquired colour vision deficiencies.
    Mailáth L
    Mod Probl Ophthalmol; 1972; 11():34-9. PubMed ID: 4544966
    [No Abstract]   [Full Text] [Related]  

  • 12. Defective colour vision in diabetic retinopathy before and after laser photocoagulation.
    Birch-Cox J
    Mod Probl Ophthalmol; 1978; 19():326-9. PubMed ID: 310054
    [No Abstract]   [Full Text] [Related]  

  • 13. Test-retest variability for standard automated perimetry and short-wavelength automated perimetry in diabetic patients.
    Bengtsson B; Hellgren KJ; Agardh E
    Acta Ophthalmol; 2008 Mar; 86(2):170-6. PubMed ID: 17935606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual acuity and colour vision tests--a preliminary report.
    Williams CM
    Br J Physiol Opt; 1976; 31(4):29-31. PubMed ID: 1053022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blue-yellow vision deficits in patients with diabetes.
    Rockett M; Anderle D; Bessman AN
    West J Med; 1987 Apr; 146(4):431-3. PubMed ID: 3495070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dyschromatopsia of optic neuritis is determined in part by the foveal/perifoveal distribution of visual field damage.
    Silverman SE; Hart WM; Gordon MO; Kilo C
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1895-902. PubMed ID: 2211035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative value of the Keely plates in diabetic retinopathy. A preliminary report.
    Yurdakul S
    Mod Probl Ophthalmol; 1978; 19():299-300. PubMed ID: 310049
    [No Abstract]   [Full Text] [Related]  

  • 18. Irreversible color vision losses in patients with chronic mercury vapor intoxication.
    Feitosa-Santana C; Barboni MT; Oiwa NN; Paramei GV; Simões AL; Da Costa MF; Silveira LC; Ventura DF
    Vis Neurosci; 2008; 25(3):487-91. PubMed ID: 18598423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Color discrimination impairment in workers exposed to mercury vapor.
    Urban P; Gobba F; Nerudová J; Lukás E; Cábelková Z; Cikrt M
    Neurotoxicology; 2003 Aug; 24(4-5):711-6. PubMed ID: 12900084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening of early color vision loss in diabetic patients].
    Peduzzi M; Longanesi L; Ascari A; Cascione S; Galletti M; Roncaia R; Pacchioni C; Maione M
    J Fr Ophtalmol; 1989; 12(11):791-6. PubMed ID: 2639899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.